161 related articles for article (PubMed ID: 24827649)
1. Mesenchymal phosphaturic tumour: early detection of recurrence.
Allevi F; Rabbiosi D; Mandalà M; Colletti G
BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24827649
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal phosphaturic neoplasm in the maxillary sinus: a case report.
Pedrazzoli M; Colletti G; Ferrari M; Rossetti G; Moneghini L; Autelitano L
Int J Oral Maxillofac Surg; 2010 Oct; 39(10):1027-32. PubMed ID: 20483563
[TBL] [Abstract][Full Text] [Related]
3. Tumour-induced osteomalacia: the long road to diagnosis and recovery.
Vollmer S; Olsson K
BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38697682
[TBL] [Abstract][Full Text] [Related]
4. Recurrent malignant variant of phosphaturic mesenchymal tumor with oncogenic osteomalacia.
Ogose A; Hotta T; Emura I; Hatano H; Inoue Y; Umezu H; Endo N
Skeletal Radiol; 2001 Feb; 30(2):99-103. PubMed ID: 11310207
[TBL] [Abstract][Full Text] [Related]
5. Left maxillary sinus tumour-induced hypophosphataemic osteomalacia and combined with thyroid papillary carcinoma: a case report and literature review.
Li B; Dong Y; Liu D; Yao Q; Guo S; Xin H; Wang H; Liu L; Zhang Y
Intern Med J; 2020 Jun; 50(6):755-761. PubMed ID: 32537923
[TBL] [Abstract][Full Text] [Related]
6. The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed?
Ledford CK; Zelenski NA; Cardona DM; Brigman BE; Eward WC
Clin Orthop Relat Res; 2013 Nov; 471(11):3618-25. PubMed ID: 23868423
[TBL] [Abstract][Full Text] [Related]
7. Varied presentation of sinonasal phosphaturic mesenchymal tumour: report of a case series with follow-up.
Kurien R; Rupa V; Thomas M
Eur Arch Otorhinolaryngol; 2019 Jun; 276(6):1677-1684. PubMed ID: 30879192
[TBL] [Abstract][Full Text] [Related]
8. Craniofacial hemangiopericytoma associated with oncogenic osteomalacia: case report.
Sandhu FA; Martuza RL
J Neurooncol; 2000; 46(3):241-7. PubMed ID: 10902855
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic osteomalacia in a case with a maxillary sinus mesenchymal tumor.
Koriyama N; Nishimoto K; Kodama T; Nakazaki M; Kurono Y; Yoshida H; Tei C
Am J Med Sci; 2006 Sep; 332(3):142-7. PubMed ID: 16969146
[TBL] [Abstract][Full Text] [Related]
10. Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation.
Horng JC; Van Eperen E; Tutton S; Singh R; Shaker JL; Wooldridge AN
Osteoporos Int; 2021 Sep; 32(9):1895-1898. PubMed ID: 33655402
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic osteomalacia presenting as bilateral stress fractures of the tibia.
Ohashi K; Ohnishi T; Ishikawa T; Tani H; Uesugi K; Takagi M
Skeletal Radiol; 1999 Jan; 28(1):46-8. PubMed ID: 10068075
[TBL] [Abstract][Full Text] [Related]
12. Phosphaturic mesenchymal tumor with symptoms related to osteomalacia that appeared one year after tumorectomy.
Yoshioka K; Nagata R; Ueda M; Yamaguchi T; Konishi Y; Hosoi M; Inoue T; Yamanaka K; Iwai Y; Sato T
Intern Med; 2006; 45(20):1157-60. PubMed ID: 17106161
[TBL] [Abstract][Full Text] [Related]
13. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
[TBL] [Abstract][Full Text] [Related]
14. Tumor-Induced Osteomalacia Caused by a Phosphaturic Mesenchymal Tumor of the Sole Presenting as a Crippling Illness in a Postmenopausal Woman.
Fang X; Zhang W; Yu Z; Liu H; Xiong Y; Luo Y; Song L; Li J; Duan H
J Foot Ankle Surg; 2020; 59(5):1113-1117. PubMed ID: 32622675
[TBL] [Abstract][Full Text] [Related]
15. [Hypophosphatemic oncogenic osteomalacia].
Mátyus J; Szebenyi B; Rédl P; Mikita J; Gáspár L; Haris A; Radó J; Kakuk G
Orv Hetil; 2000 Dec; 141(51):2785-8. PubMed ID: 11196239
[TBL] [Abstract][Full Text] [Related]
16. Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report.
Tartaglia F; Minisola S; Sgueglia M; Blasi S; Brunelli D; Degli Effetti E; Maturo A; Cola A; Custureri F; Campana FP
G Chir; 2006; 27(1-2):9-13. PubMed ID: 16608626
[TBL] [Abstract][Full Text] [Related]
17. Neoplastic pathology of oncogenic osteomalacia/rickets.
Weidner N; Bar RS; Weiss D; Strottmann MP
Cancer; 1985 Apr; 55(8):1691-705. PubMed ID: 3978561
[TBL] [Abstract][Full Text] [Related]
18. Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.
Hu FK; Yuan F; Jiang CY; Lv DW; Mao BB; Zhang Q; Yuan ZQ; Wang Y
Chin J Cancer; 2011 Nov; 30(11):794-804. PubMed ID: 22035861
[TBL] [Abstract][Full Text] [Related]
19. Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients.
Zuo QY; Wang H; Li W; Niu XH; Huang YH; Chen J; You YH; Liu BY; Cui AM; Deng W
BMC Musculoskelet Disord; 2017 Sep; 18(1):403. PubMed ID: 28934935
[TBL] [Abstract][Full Text] [Related]
20. Osteomalacia-Inducing Tumors of the Brain: A Case Report, Review and a Hypothesis.
Fathalla H; Cusimano M; Di Ieva A; Karamchandani J; Fung R; Kovacs K
World Neurosurg; 2015 Jul; 84(1):189.e1-5. PubMed ID: 25746588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
